Nonresponse to tumor necrosis factor antagonists--is there any point in re-treatment?

Nat Clin Pract Rheumatol. 2006 Jun;2(6):288-9. doi: 10.1038/ncprheum0210.
No abstract available

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / metabolism
  • Humans
  • Prognosis
  • Retreatment
  • Treatment Failure
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha